Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Affinity enhancement immunological reagents for in vivo detection and killing of specific target cells

Affinity enhancement immunological reagents for in vivo detection and killing of specific target cells

US Patent 5256395 · Granted Oct 26, 1993

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic 2023
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)2022
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strat2020
Human IgG1 derived antibody with pro-apoptotic activity2020
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity2020
Cosmetic composition comprising a muconopeptide2018
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strat2018
Neurotensin analogues for radioisotope targeting to neurotensin receptor-positiv2017
Cosmetic composition comprising a muconopeptide2017
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2016
Use of monoclonal antibodies specific to the O-acetylated form of GD2 gangliosid2015
Incubation device for serology and histology slides2013